These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3581709)

  • 1. Evaluation of different formulae for the study of platelet survival.
    Strydom WJ; Van Reenen OR; Pilloy WJ
    Clin Phys Physiol Meas; 1987 Feb; 8(1):57-63. PubMed ID: 3581709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of computerized formulae for determination of platelet recovery and survival.
    Aubuchon JP; Herschel L; Roger J; Dumont L; Murphy S; Slichter SJ; Whitley P; Snyder E; Goodrich RP
    Transfusion; 2005 Jul; 45(7):1237-9. PubMed ID: 15987377
    [No Abstract]   [Full Text] [Related]  

  • 3. A biological approach to the platelet survival curve with criticism of previous interpretations.
    Trowbridge EA; Martin JF
    Phys Med Biol; 1983 Dec; 28(12):1349-68. PubMed ID: 6665030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the methods calculating mean survival time in 51Cr-platelet survival study.
    Tsukada T; Tango T
    Am J Hematol; 1980; 8(3):281-90. PubMed ID: 7416159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommended method for indium-111 platelet survival studies. International Committee for Standardization in Hematology. Panel on Diagnostic Applications of Radionuclides.
    J Nucl Med; 1988 Apr; 29(4):564-6. PubMed ID: 3351612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo recovery and survival of apheresis and whole blood-derived platelets: a paired comparison in healthy volunteers.
    Arnold DM; Heddle NM; Kulczycky M; Carruthers J; Sigouin C; Blajchman MA
    Transfusion; 2006 Feb; 46(2):257-64. PubMed ID: 16441604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet regeneration time after aspirin ingestion and platelet survival time after labelling with 51chromium or 111indium oxine--a comparative study.
    Boneu A; Sié P; Bugat R; Caranobe C; Eber M; Cazenave JP; Boneu B
    Thromb Haemost; 1985 Apr; 53(2):260-3. PubMed ID: 3927506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo behavior of 111In-labelled platelets: an experimental study of healthy male volunteers.
    Wadenvik H; Jacobsson S; Kutti J; Syrjälä M
    Eur J Haematol; 1987 May; 38(5):415-25. PubMed ID: 3653363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of mathematic models to assess platelet kinetics.
    Lötter MG; Heyns AD; Badenhorst PN; Wessels P; Martin van Zyl J; Kotze HF; Minnaar PC
    J Nucl Med; 1986 Jul; 27(7):1192-201. PubMed ID: 3088224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mathematical processing of human platelet distribution according to size for determination of cell heterogeneity].
    Kosmovskiĭ SIu; Vasin SL; Rozanova IB; Sevast'ianov VI
    Med Tekh; 1999; (6):41-3. PubMed ID: 10693126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of baboon biotin-X-N-hydroxysuccinimide and (111)In-oxine-labelled autologous fresh and lyophilized reconstituted platelets.
    Valeri CR; MacGregor H; Barnard MR; Summaria L; Michelson AD; Ragno G
    Vox Sang; 2005 Feb; 88(2):122-9. PubMed ID: 15720610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Platelet weighted mean survival time estimated by platelet and whole blood method].
    Saito K; Murata H; Tsukada T
    Kaku Igaku; 1988 Aug; 25(8):767-73. PubMed ID: 3193651
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet survival, atherosclerotic intermittent claudication and ticlopidine.
    Hawker RJ; Aukland A
    Atherosclerosis; 1984 Feb; 50(2):147-58. PubMed ID: 6712768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 111In-tropolonate labelled platelets; studies in normals and in patients with thrombocytopenia.
    Louwes H; Beekhuis H; Goedemans WT; Keijser SP; Schuurman JJ
    Eur J Nucl Med; 1987; 13(1):47-51. PubMed ID: 3109918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro evaluation of platelet concentrates during storage: Platelet counts and markers of platelet destruction.
    Apelseth TO; Hervig T
    Transfus Apher Sci; 2007 Dec; 37(3):261-8. PubMed ID: 18036986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A computer program in compiled BASIC for the IBM personal computer to calculate the mean platelet survival time with the multiple-hit and weighted mean methods.
    Lötter MG; Rabe WL; Van Zyl JM; Heyns AD; Wessels P; Kotzé HF; Minnaar PC
    Comput Biol Med; 1988; 18(4):305-15. PubMed ID: 3409677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of In-111-platelets in the baboon: I. Isolation and labelling of a viable and representative platelet population.
    Kotzé HF; Lötter MG; Badenhorst PN; Heyns AD
    Thromb Haemost; 1985 Jun; 53(3):404-7. PubMed ID: 4049310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet size analysis in the quality assurance of platelet concentrates for transfusion.
    Farrugia A
    Clin Lab Haematol; 1995 Mar; 17(1):51-5. PubMed ID: 7621629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommended methods for radioisotope platelet survival studies: by the panel on Diagnostic Application of Radioisotopes in Hematology, International Committee for Standardization in Hematology.
    Blood; 1977 Dec; 50(6):1137-44. PubMed ID: 922161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.